Literature DB >> 32948687

Chemokine Signatures of Pathogen-Specific T Cells I: Effector T Cells.

Jens Eberlein1,2, Bennett Davenport1,2,3,4,5, Tom T Nguyen1,2,3, Francisco Victorino1,2,3, Kevin Jhun4,5, Verena van der Heide4,5, Maxim Kuleshov6,7, Avi Ma'ayan6,7, Ross Kedl2, Dirk Homann8,2,3,4,5.   

Abstract

The choreography of complex immune responses, including the priming, differentiation, and modulation of specific effector T cell populations generated in the immediate wake of an acute pathogen challenge, is in part controlled by chemokines, a large family of mostly secreted molecules involved in chemotaxis and other patho/physiological processes. T cells are both responsive to various chemokine cues and a relevant source for certain chemokines themselves; yet, the actual range, regulation, and role of effector T cell-derived chemokines remains incompletely understood. In this study, using different in vivo mouse models of viral and bacterial infection as well as protective vaccination, we have defined the entire spectrum of chemokines produced by pathogen-specific CD8+ and CD4+T effector cells and delineated several unique properties pertaining to the temporospatial organization of chemokine expression patterns, synthesis and secretion kinetics, and cooperative regulation. Collectively, our results position the "T cell chemokine response" as a notably prominent, largely invariant, yet distinctive force at the forefront of pathogen-specific effector T cell activities and establish novel practical and conceptual approaches that may serve as a foundation for future investigations into the role of T cell-produced chemokines in infectious and other diseases.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Year:  2020        PMID: 32948687      PMCID: PMC7541659          DOI: 10.4049/jimmunol.2000253

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  121 in total

Review 1.  RANTES: a versatile and controversial chemokine.

Authors:  V Appay; S L Rowland-Jones
Journal:  Trends Immunol       Date:  2001-02       Impact factor: 16.687

2.  Preferential localization of effector memory cells in nonlymphoid tissue.

Authors:  D Masopust; V Vezys; A L Marzo; L Lefrançois
Journal:  Science       Date:  2001-03-01       Impact factor: 47.728

3.  The immunological synapse: a molecular machine controlling T cell activation.

Authors:  A Grakoui; S K Bromley; C Sumen; M M Davis; A S Shaw; P M Allen; M L Dustin
Journal:  Science       Date:  1999-07-09       Impact factor: 47.728

4.  RANTES production by memory phenotype T cells is controlled by a posttranscriptional, TCR-dependent process.

Authors:  Bradley J Swanson; Masaaki Murakami; Thomas C Mitchell; John Kappler; Philippa Marrack
Journal:  Immunity       Date:  2002-11       Impact factor: 31.745

5.  Cell cycle-related acquisition of cytotoxic mediators defines the progressive differentiation to effector status for virus-specific CD8+ T cells.

Authors:  Misty R Jenkins; Justine Mintern; Nicole L La Gruta; Katherine Kedzierska; Peter C Doherty; Stephen J Turner
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

6.  CCL5-CCR5-mediated apoptosis in T cells: Requirement for glycosaminoglycan binding and CCL5 aggregation.

Authors:  Thomas T Murooka; Mark M Wong; Ramtin Rahbar; Beata Majchrzak-Kita; Amanda E I Proudfoot; Eleanor N Fish
Journal:  J Biol Chem       Date:  2006-06-28       Impact factor: 5.157

7.  TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice.

Authors:  Thomas Calzascia; Marc Pellegrini; Håkan Hall; Laurent Sabbagh; Nobuyuki Ono; Alisha R Elford; Tak W Mak; Pamela S Ohashi
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

8.  JNK MAPK pathway regulates constitutive transcription of CCL5 by human NK cells through SP1.

Authors:  Dilip Kumar; Judith Hosse; Christine von Toerne; Elfriede Noessner; Peter J Nelson
Journal:  J Immunol       Date:  2009-01-15       Impact factor: 5.422

9.  Antibody targeting of the CC chemokine ligand 5 results in diminished leukocyte infiltration into the central nervous system and reduced neurologic disease in a viral model of multiple sclerosis.

Authors:  William G Glass; Michelle J Hickey; Jenny L Hardison; Michael T Liu; Jerry E Manning; Thomas E Lane
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

10.  A role for the chemokine RANTES in regulating CD8 T cell responses during chronic viral infection.

Authors:  Alison Crawford; Jill Marie Angelosanto; Kim Lynn Nadwodny; Shawn D Blackburn; E John Wherry
Journal:  PLoS Pathog       Date:  2011-07-21       Impact factor: 6.823

View more
  10 in total

1.  Chemokine Signatures of Pathogen-Specific T Cells II: Memory T Cells in Acute and Chronic Infection.

Authors:  Bennett Davenport; Jens Eberlein; Tom T Nguyen; Francisco Victorino; Verena van der Heide; Maxim Kuleshov; Avi Ma'ayan; Ross Kedl; Dirk Homann
Journal:  J Immunol       Date:  2020-09-18       Impact factor: 5.422

2.  Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment.

Authors:  William L Hwang; Karthik A Jagadeesh; Jimmy A Guo; Hannah I Hoffman; Payman Yadollahpour; Jason W Reeves; Rahul Mohan; Eugene Drokhlyansky; Nicholas Van Wittenberghe; Orr Ashenberg; Samouil L Farhi; Denis Schapiro; Prajan Divakar; Eric Miller; Daniel R Zollinger; George Eng; Jason M Schenkel; Jennifer Su; Carina Shiau; Patrick Yu; William A Freed-Pastor; Domenic Abbondanza; Arnav Mehta; Joshua Gould; Conner Lambden; Caroline B M Porter; Alexander Tsankov; Danielle Dionne; Julia Waldman; Michael S Cuoco; Lan Nguyen; Toni Delorey; Devan Phillips; Jaimie L Barth; Marina Kem; Clifton Rodrigues; Debora Ciprani; Jorge Roldan; Piotr Zelga; Vjola Jorgji; Jonathan H Chen; Zackery Ely; Daniel Zhao; Kit Fuhrman; Robin Fropf; Joseph M Beechem; Jay S Loeffler; David P Ryan; Colin D Weekes; Cristina R Ferrone; Motaz Qadan; Martin J Aryee; Rakesh K Jain; Donna S Neuberg; Jennifer Y Wo; Theodore S Hong; Ramnik Xavier; Andrew J Aguirre; Orit Rozenblatt-Rosen; Mari Mino-Kenudson; Carlos Fernandez-Del Castillo; Andrew S Liss; David T Ting; Tyler Jacks; Aviv Regev
Journal:  Nat Genet       Date:  2022-07-28       Impact factor: 41.307

3.  Aging-dependent regulatory cells emerge in subcutaneous fat to inhibit adipogenesis.

Authors:  Hai P Nguyen; Frances Lin; Danielle Yi; Ying Xie; Jennie Dinh; Pengya Xue; Hei Sook Sul
Journal:  Dev Cell       Date:  2021-04-19       Impact factor: 12.270

4.  Memory CD8+ T cells mediate early pathogen-specific protection via localized delivery of chemokines and IFNγ to clusters of monocytes.

Authors:  Marie Boutet; Zachary Benet; Erik Guillen; Caroline Koch; Saidi M'Homa Soudja; Fabien Delahaye; David Fooksman; Grégoire Lauvau
Journal:  Sci Adv       Date:  2021-09-01       Impact factor: 14.136

5.  Characterizing cell interactions at scale with made-to-order droplet ensembles (MODEs).

Authors:  Justin L Madrigal; Nathan G Schoepp; Linfeng Xu; Codian S Powell; Cyrille L Delley; Christian A Siltanen; Jay Danao; Maithreyan Srinivasan; Russell H Cole; Adam R Abate
Journal:  Proc Natl Acad Sci U S A       Date:  2022-02-01       Impact factor: 11.205

6.  Contribution of CD4+ T cell-mediated inflammation to diarrhea in patients with COVID-19.

Authors:  Xiaobing Wang; Jia Wei; Ruiping Zhu; Liping Chen; Feng Ding; Rui Zhou; Liuqing Ge; Jun Xiao; Qiu Zhao
Journal:  Int J Infect Dis       Date:  2022-04-06       Impact factor: 12.074

7.  Infection with the SARS-CoV-2 B.1.351 variant is lethal in aged BALB/c mice.

Authors:  Fumihiko Yasui; Yusuke Matsumoto; Naoki Yamamoto; Takahiro Sanada; Tomoko Honda; Tsubasa Munakata; Yasushi Itoh; Michinori Kohara
Journal:  Sci Rep       Date:  2022-03-09       Impact factor: 4.379

8.  Single-cell gene expression analysis of cryopreserved equine bronchoalveolar cells.

Authors:  Sophie E Sage; Pamela Nicholson; Laureen M Peters; Tosso Leeb; Vidhya Jagannathan; Vinzenz Gerber
Journal:  Front Immunol       Date:  2022-08-29       Impact factor: 8.786

9.  Phosphoinositide 3-Kinase p110 Delta Differentially Restrains and Directs Naïve Versus Effector CD8+ T Cell Transcriptional Programs.

Authors:  Laura Spinelli; Julia M Marchingo; Aneela Nomura; Marcos P Damasio; Doreen A Cantrell
Journal:  Front Immunol       Date:  2021-06-18       Impact factor: 7.561

10.  Stratification of COVID-19 patients based on quantitative immune-related gene expression in whole blood.

Authors:  Josefine Persson; Björn Andersson; Suzanne van Veen; Mariëlle C Haks; Ogonna Obudulu; Sara Torkzadeh; Tom H M Ottenhoff; Nelly Kanberg; Magnus Gisslén; Lars-Magnus Andersson; Ali M Harandi
Journal:  Mol Immunol       Date:  2022-03-04       Impact factor: 4.407

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.